Bioequivalence Study Chiglitazar Metformin T2DM

ClinicalTrials.gov published a new trial registration for a bioequivalence study comparing Chiglitazar combined with Metformin against reference products in Type 2 Diabetes Mellitus patients. The study is listed as recruiting with 36 participants at one China site. Trial registration on ClinicalTrials.gov is required under FDAAA 801 for applicable clinical trials.

Clinical investigators and sponsors should ensure trial registration is current and complete on ClinicalTrials.gov. FDAAA 801 requires registration and results reporting for applicable clinical trials of drugs and devices, with potential penalties for non-compliance.